Skip to main content
All lobbying clients

ACESSO BIOLOGICS

Lobbying client · Nevada · filed 2025 to 2026

Biologics Company

$370,000 Reported spend
8 Filings counted
1 Outside firm hired
3 Bills named

Spend is reported income plus in-house expenses across 8 filings. Everything on this page comes from one LDA client record (64413), filed by the registrant listed below.

 Who filed for this client 1

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 3
  • S. 2561
    Skin Substitute Access and Payment Reform Act of 2025
    5 filings
  • H.R. 5768
    Skin Substitute Access and Payment Reform Act
    4 filings
  • H.R. 6852
    Advanced Wound Care and Regenerative Medicine Access and Reform Act
    4 filings
 Reported by year 2 years
  • 2026 $180,000 3 filings
  • 2025 $190,000 5 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 7
  • SENATE 7
  • Centers For Medicare and Medicaid Services (CMS) 4
  • Health & Human Services, Dept of (HHS) 4
  • Office of Management & Budget (OMB) 4
 Recent filings 8 total
Q3 report
THE MCMANUS GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View → Q2 report
THE MCMANUS GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View → Q1 report
THE MCMANUS GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View → Q4 report
THE MCMANUS GROUP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View → Q3 report
THE MCMANUS GROUP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View → Q2 report
THE MCMANUS GROUP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Aug 4, 2025
View → Q1 report
THE MCMANUS GROUP
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 21, 2025
View → Registration
THE MCMANUS GROUP
1st Quarter 2025 (Jan 1 - Mar 31) · posted Feb 21, 2025
View →
 Affiliated organisations 1
  • ACESSO BIOLOGICS United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem